Entrada Therapeutics
TRDA
TRDA
52 hedge funds and large institutions have $361M invested in Entrada Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
0.83%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
9
Increased
24
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$2.86M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2.85M |
| 3 |
3
Jane Street
New York
|
$1.07M |
| 4 |
CA
4
CHI Advisors
New York
|
$817K |
| 5 |
HF
5
HRT Financial
New York
|
$556K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Osaic Holdings
Scottsdale,
Arizona
| $4.35K | 300 | – | – |
|
52
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2.9K | 200 | +200 | New |
|
53
Wells Fargo
San Francisco,
California
| $2.45K | 169 | +1 | +0.6% |
|
|
E
54
Ergoteles
New York
| – | – | -14,019 | Closed |
|
55
Balyasny Asset Management
Chicago,
Illinois
| – | – | -12,132 | Closed |
|
56
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | – | -10,971 | Closed |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -28 | Closed |
|
|
CFGS
58
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|